0000899243-21-024236.txt : 20210616 0000899243-21-024236.hdr.sgml : 20210616 20210616184644 ACCESSION NUMBER: 0000899243-21-024236 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210616 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gall Matthew CENTRAL INDEX KEY: 0001816194 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39401 FILM NUMBER: 211022776 MAIL ADDRESS: STREET 1: C/O ITEOS THERAPEUTICS, INC. STREET 2: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: iTeos Therapeutics, Inc. CENTRAL INDEX KEY: 0001808865 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 857-204-4583 MAIL ADDRESS: STREET 1: 139 MAIN STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-16 0 0001808865 iTeos Therapeutics, Inc. ITOS 0001816194 Gall Matthew C/O ITEOS THERAPEUTICS, INC., 139 MAIN STREET CAMBRIDGE MA 02142 0 1 0 0 Chief Financial Officer Common Stock 2021-06-16 4 P 0 5000 26.0893 A 5000 D The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $25.84 to $26.15. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request. /s/ Michel Detheux, as Attorney-in-Fact 2021-06-16